HSIC
62
-3
DHI
40
3
O
35
4
GT
39
2
MMC
60
3
OMC
55
-7
URBN
54
2
EQR
47
2
CRM
59
-11
HBAN
82
2
SWKS
56
8
NKE
36
6
ETR
52
3
XRAY
28
3
HPE
68
-5
ROK
47
-3
ETN
61
2
MO
57
4
SO
53
5
TROW
61
2
HSIC
62
-3
DHI
40
3
O
35
4
GT
39
2
MMC
60
3
OMC
55
-7
URBN
54
2
EQR
47
2
CRM
59
-11
HBAN
82
2
SWKS
56
8
NKE
36
6
ETR
52
3
XRAY
28
3
HPE
68
-5
ROK
47
-3
ETN
61
2
MO
57
4
SO
53
5
TROW
61
2
Financhill
Back

YieldMax Short TSLA Option Income Strategy ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
31

CRSH
YieldMax Short TSLA Option Income Strategy ETF

Last Price:
$24.33
Seasonality Move:
-15.4%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.7200
Seasonality Move:
33.23%
Sell
31
YieldMax Short TSLA Option Income Strategy ETF (CRSH) is a Sell

Is YieldMax Short TSLA Option Income Strategy ETF a Buy, Sell or Hold?

  • The current YieldMax Short TSLA Option Income Strategy ETF [CRSH] share price is $24.57. The Score for CRSH is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CRSH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CRSH Stock Price Chart

What is YieldMax Short TSLA Option Income Strategy ETF's stock price today?

  • The YieldMax Short TSLA Option Income Strategy ETF share price today is $24.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSH is experiencing slight selling pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

CRSH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.2 Sell
Relative Strength Index (14 RSI): 34.57 Sell
Chaikin Money Flow: -2259 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.06 - 29.02) Sell
Bollinger Bands (100): (26.67 - 37.91) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

CRSH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.88 Sell
20-day SMA: 26.28 Sell
50-day SMA: 28.1 Sell
200-day SMA: 44.48 Sell
8-day EMA: 24.98 Sell
20-day EMA: 26.14 Sell
50-day EMA: 28.39 Sell
200-day EMA: 48.13 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

YieldMax Short TSLA Option Income Strategy ETF Earnings Growth & CRSH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

YieldMax Short TSLA Option Income Strategy ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):